EisenA, StewartH, SchulzerM, CameronD.Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine. Can J Neurol Sci1993; 20: 297–301.
4.
BensimanG, LacomblezL, MeiningerV.A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med1994; 330: 585–91.
5.
PlaitakisA.Altered glutaminergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: possible role of glycine. Adv Neurol1991; 56: 319–26.
6.
PriceDL, KoliatsobVE, ClatterbuckRC. Cholinergic systems: human diseases, animal models, and prospects for therapy. Prog Brain Res1993; 98: 51–60.
7.
RothsteinJD, MartinLJ, KunciRW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med1992; 326: 1464–8.
8.
TaylorCP. Emerging perspectives on the mechanism of action of gabapentin. Neurology1994; 44(suppl 5):S10–6.
9.
McLeanMJ. Clinical pharmacokinetics of gabapentin. Neurology1994; 44(suppl 5):S17–22.
10.
GoaKL, RossSR, ChrispP.Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs1993; 46: 152–76.
